Выбор редакции

7 Stocks Making Big M&A News and Rumors This Week

AstraZeneca announced on Tuesday that it will acquire Omthera Pharmaceuticals for up to $443 million, so as to reinforce its cardiovascular drug business, which is a priority area for the United Kingdom's number two drugmaker.

НОВОСТИ ПО ТЕМЕ